BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35860950)

  • 41. A TaqMan Probe-Based Real-Time PCR Assay for the Rapid Identification of the Emerging Multidrug-Resistant Pathogen Candida auris on the BD Max System.
    Lima A; Widen R; Vestal G; Uy D; Silbert S
    J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31068411
    [No Abstract]   [Full Text] [Related]  

  • 42. South Asian (Clade I) Candida auris meningitis in a paediatric patient in Iran with a review of the literature.
    Mirhendi H; Charsizadeh A; Aboutalebian S; Mohammadpour M; Nikmanesh B; de Groot T; Meis JF; Badali H
    Mycoses; 2022 Feb; 65(2):134-139. PubMed ID: 34780087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Candida auris otomycosis in Iran and review of recent literature.
    Abastabar M; Haghani I; Ahangarkani F; Rezai MS; Taghizadeh Armaki M; Roodgari S; Kiakojuri K; Al-Hatmi AMS; Meis JF; Badali H
    Mycoses; 2019 Feb; 62(2):101-105. PubMed ID: 30585653
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multidrug-resistant endemic clonal strain of Candida auris in India.
    Chowdhary A; Anil Kumar V; Sharma C; Prakash A; Agarwal K; Babu R; Dinesh KR; Karim S; Singh SK; Hagen F; Meis JF
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):919-26. PubMed ID: 24357342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.
    Lockhart SR; Etienne KA; Vallabhaneni S; Farooqi J; Chowdhary A; Govender NP; Colombo AL; Calvo B; Cuomo CA; Desjardins CA; Berkow EL; Castanheira M; Magobo RE; Jabeen K; Asghar RJ; Meis JF; Jackson B; Chiller T; Litvintseva AP
    Clin Infect Dis; 2017 Jan; 64(2):134-140. PubMed ID: 27988485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emergence of Candida auris in intensive care units in Algeria.
    Zerrouki H; Ibrahim A; Rebiahi SA; Elhabiri Y; Benhaddouche DE; de Groot T; Meis JF; Rolain JM; Bittar F
    Mycoses; 2022 Jul; 65(7):753-759. PubMed ID: 35546294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Rapid and Automated Sample-to-Result Candida auris Real-Time PCR Assay for High-Throughput Testing of Surveillance Samples with the BD Max Open System.
    Leach L; Russell A; Zhu Y; Chaturvedi S; Chaturvedi V
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31391229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Are We Ready for Nosocomial
    De Carolis E; Marchionni F; La Rosa M; Meis JF; Chowdhary A; Posteraro B; Sanguinetti M
    Front Cell Infect Microbiol; 2021; 11():645049. PubMed ID: 33796487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular apoptosis and cell cycle arrest as potential therapeutic targets for eugenol derivatives in Candida auris.
    Alam H; Srivastava V; Sekgele W; Wani MY; Al-Bogami AS; Molepo J; Ahmad A
    PLoS One; 2023; 18(6):e0285473. PubMed ID: 37343020
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance.
    Escandón P; Chow NA; Caceres DH; Gade L; Berkow EL; Armstrong P; Rivera S; Misas E; Duarte C; Moulton-Meissner H; Welsh RM; Parra C; Pescador LA; Villalobos N; Salcedo S; Berrio I; Varón C; Espinosa-Bode A; Lockhart SR; Jackson BR; Litvintseva AP; Beltran M; Chiller TM
    Clin Infect Dis; 2019 Jan; 68(1):15-21. PubMed ID: 29788045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of CHROMagar
    Bentz ML; Le N; Min B; Nunnally NS; Sullivan V; Tran M; Lockhart SR; Litvintseva A; Berkow EL; Sexton DJ
    Microbiol Spectr; 2024 Apr; 12(4):e0356423. PubMed ID: 38364098
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of screening for Candida auris colonisation in international patients admitted to a large university hospital.
    Heindel J; Zweigner J; Fuchs F; Hamprecht A
    Mycoses; 2023 Feb; 66(2):138-143. PubMed ID: 36135346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methods for identification of Candida auris, the yeast of global public health concern: A review.
    Mahmoudi S; Agha Kuchak Afshari S; Aghaei Gharehbolagh S; Mirhendi H; Makimura K
    J Mycol Med; 2019 Jun; 29(2):174-179. PubMed ID: 31031132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Direct Detection of Emergent Fungal Pathogen Candida auris in Clinical Skin Swabs by SYBR Green-Based Quantitative PCR Assay.
    Sexton DJ; Kordalewska M; Bentz ML; Welsh RM; Perlin DS; Litvintseva AP
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232130
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis, management and prevention of Candida auris in hospitals: position statement of the Australasian Society for Infectious Diseases.
    Ong CW; Chen SC; Clark JE; Halliday CL; Kidd SE; Marriott DJ; Marshall CL; Morris AJ; Morrissey CO; Roy R; Slavin MA; Stewardson AJ; Worth LJ; Heath CH;
    Intern Med J; 2019 Oct; 49(10):1229-1243. PubMed ID: 31424595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Measuring Gene Expression via mRNA Abundance in Candida auris.
    Wasi M; Nair R; Khandelwal NK; Prasad R
    Methods Mol Biol; 2022; 2517():155-164. PubMed ID: 35674951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Confirmation of fifth
    Spruijtenburg B; Badali H; Abastabar M; Mirhendi H; Khodavaisy S; Sharifisooraki J; Taghizadeh Armaki M; de Groot T; Meis JF
    Emerg Microbes Infect; 2022 Dec; 11(1):2405-2411. PubMed ID: 36154919
    [No Abstract]   [Full Text] [Related]  

  • 59. Clinical isolates of Candida auris with enhanced adherence and biofilm formation due to genomic amplification of ALS4.
    Bing J; Guan Z; Zheng T; Zhang Z; Fan S; Ennis CL; Nobile CJ; Huang G
    PLoS Pathog; 2023 Mar; 19(3):e1011239. PubMed ID: 36913408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates
    Wiederhold NP; Lockhart SR; Najvar LK; Berkow EL; Jaramillo R; Olivo M; Garvey EP; Yates CM; Schotzinger RJ; Catano G; Patterson TF
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30530603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.